Determinants of Cervical Cancer Screening among Women with Intellectual Disabilities: Evidence from Medical Records

Abstract

Objective. We examined receipt of cervical cancer screening and determinants of screening for women with intellectual disabilities in one Southeastern state.Methods. Using medical records data from 2006 through 2010 for communitydwelling women with intellectual disabilities who were 18-65 years of age (n5163), we employed descriptive and bivariate statistics and a multivariate regression model to examine receipt of cervical cancer screening and the determinants of cervical cancer screening across women's sociodemographic and health-care provider characteristics.Results. Of women 18-65 years of age with intellectual disabilities, 55% received a Papanicolaou (Pap) test during 2008-2010, markedly below the Healthy People 2020 targets or rates of Pap test receipt of women without intellectual disabilities. Women with intellectual disabilities who lived in residential facilities, those who lived in rural communities, and those who had an obstetrician/gynecologist had higher rates of receipt of care than other women with intellectual disabilities.Conclusions. Assertive measures are required to improve the receipt of cervical cancer screening among women with intellectual disabilities. Such measures could include education of women with intellectual disabilities, as well as their paid and family caregivers, and incentives for health-care providers who achieve screening targets.

A longitudinal assessment of adherence to breast and cervical cancer screening recommendations among women with and without intellectual disability

“…Full adherence rates for Pap testing may also be impacted by previous difficulties due to anxiety or coexisting physical impairments (Tyler et al, 2010; Gajdosik and Cicirello, 2002; Krigger, 2006; Rapp and Torres, 2000). These concerns may be magnified in the context of doubts among physicians about the need for Pap testing due to low rates of cytologic abnormalities in women with ID (Quint and Elkins, 1997; Jaffe et al, 2002; Parish, 2013). …”

TNFAIP8 promotes cisplatin resistance in cervical carcinoma cells by inhibiting cellular apoptosis

“…Cervical cancer is the second most prevalent malignant tumor in women worldwide and the fourth leading cause of cancer-associated mortalities among women (1,2). Surgery, chemotherapy and radiotherapy are the standard treatment options for patients with cervical cancer; however, the 5 year survival rate for advanced and recurrent cervical cancer is only 10-20%; with metastasis and chemotherapeutic agent resistance being the principal causes of treatment failure (3).…”

Test of an intervention to improve knowledge of women with intellectual disabilities about cervical and breast cancer screening

“…Cervical and breast cancer screenings are an important component of preventive health because they increase the likelihood that cancers are detected in early stages when treatment is more likely to be successful. Women with IDs receive cervical and breast cancer screening at lower rates than non-disabled women (Lewis et al 2002;Havercamp et al 2004;Iacono & Sutherland 2006;Parish & Saville 2006;Parish et al 2013). Screening barriers include limited knowledge (Sullivan et al 2004b;Brown & Gill 2009;McIlfatrick et al 2011;Taggart et al 2011;Truesdale-Kennedy et al 2011;Wilkinson et al 2011;Parish et al 2012b), fear and anxiety (Sullivan et al 2004b;Taggart et al 2011;Truesdale-Kennedy et al 2011), and the need for sedation (Tyler et al 2010).…”

“…; Iacono & Sutherland ; Parish & Saville ; Parish et al . ). Screening barriers include limited knowledge (Sullivan et al .…”